Sites: CDL-Oxford, CDL-Toronto, CDL-Vancouver, CDL-Wisconsin
Stream: Advanced Therapies
Jim Banting (PhD) is the assistant vice-principal (partnerships and innovation) at Queen’s University in Kingston, Ontario. His career began as a co-founder of the Queen’s University spin-off company that was venture capital-funded, grown, and sold to a U.S. specialty pharmaceutical company. A large portion of his career has focused on partnerships, alliance management, licensing, and M&A in the the U.S. and Canadian biotech sectors. Jim has scientific and business development experience with antibodies, small molecules, medical devices, diagnostics, and cell/gene therapies modalities together with oncology, immunology, GI, hepatology, and cardiovascular therapeutic areas.